Clinical Trial Update: A Phase II Study of Topotecan in Children With Recurrent Wilms Tumor [Phase 2]

View source ↗

Summary

A Phase II study of topotecan in children with recurrent Wilms tumor has completed enrollment/status. The document provides a trial update without detailing eff…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wilms Tumor

Drugs mentioned

• Topotecan (topotecan)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Wilms Tumor | Phase 2 | Status: COMPLETED